Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI)

P Rettman; F Malard; N Legrand; O Avinens; J-F Eliaou; C Picard; A Dormoy; X Lafarge; M de Matteis; A Kennel; P Loiseau; A Devys; A Boudifa; L Absi; M Fort; D Masson; F Quainon; I Theodorou; A Batho; A Parissiadis; F Delbos; M Drouet; D Senitzer; E Marry; N Raus; I Yakoub-Agha; A Cesbron; C Retière; K Gagne

doi:10.1038/bmt.2016.151

Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI)

Bone Marrow Transplant. 2016 Nov;51(11):1499-1503. doi: 10.1038/bmt.2016.151. Epub 2016 Jun 6.

Authors

P Rettman¹, F Malard^{2

3}, N Legrand¹, O Avinens⁴, J-F Eliaou^{4

5}, C Picard⁶, A Dormoy⁷, X Lafarge⁸, M de Matteis⁹, A Kennel¹⁰, P Loiseau^{11

12}, A Devys^{2

13}, A Boudifa¹⁴, L Absi¹⁵, M Fort¹⁶, D Masson¹⁷, F Quainon¹⁸, I Theodorou¹⁹, A Batho²⁰, A Parissiadis²¹, F Delbos²², M Drouet²³, D Senitzer²⁴, E Marry²⁵, N Raus²⁶, I Yakoub-Agha²⁶, A Cesbron^{2

12}, C Retière¹, K Gagne^{1

2

12}

Affiliations

¹ Research Department EA4271, Université, EFS Nantes, Nantes, France.
² HLA Department, EFS Nantes, Nantes, France.
³ Hematology Department, CHU Hotel Dieu Nantes, Nantes, France.
⁴ Immunology Department, CHU Montpellier, Montpellier, France.
⁵ Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI), Paris, France.
⁶ HLA Department, UMR 7268, Université Aix-Marseille, EFS Marseille, Marseille, France.
⁷ HLA Department, EFS Besançon, Besançon, France.
⁸ HLA Department, EFS Bordeaux, Bordeaux, France.
⁹ HLA Department, CHU Nice, Nice, France.
¹⁰ HLA laboratory, CHU Nancy, Nancy, France.
¹¹ HLA Department, Inserm UMR940, AP-HP Paris Saint Louis, Paris, France.
¹² Labex Transplantex, Université Strasbourg, Strasbourg, France.
¹³ HLA Department, EFS Angers, Angers, France.
¹⁴ HLA Department, AP-HP Paris Saint-Antoine, Paris, France.
¹⁵ HLA Department, EFS Saint-Etienne, Saint-Etienne, France.
¹⁶ HLA Department, CHU Toulouse, Toulouse, France.
¹⁷ HLA Department, EFS Grenoble, Grenoble, France.
¹⁸ HLA Department, EFS Clermont-Ferrand, Clermont-Ferrand, France.
¹⁹ Immunology Department, Pitié Salpêtrière Charles Foix, Paris, France.
²⁰ HLA Department, EFS Caen, Caen, France.
²¹ HLA Department, EFS Strasbourg, Strasbourg, France.
²² HLA Department, EFS Créteil, Paris, France.
²³ HLA Department, CHU Limoges, Limoges, France.
²⁴ Division of Hematology and Bone Marrow Transplantation, City of Hope, National Medical Center, Duarte, CA, USA.
²⁵ Registre France Greffe de Moelle (RFGM), Saint-Denis La Plaine, France.
²⁶ Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Paris, France.

PMID: 27272444
DOI: 10.1038/bmt.2016.151

No abstract available

Publication types

Letter
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Cord Blood Stem Cell Transplantation / methods*
France
HLA Antigens / genetics*
Humans
Receptors, KIR / genetics*
Retrospective Studies
Transplantation Immunology
Treatment Outcome

Substances

HLA Antigens
Receptors, KIR